3.1.1. to coordinate the drafting of national legislation required for the implementation of Regulation (EU) No 528/2012;

3.1.2. to provide notifications to the Commission laid down in Regulation (EU) No 528/2012 on the national legislation for the implementation of Regulation (EU) No 528/2012;

3.4.1. to participate in the meetings of the Biocidal Products Committee, the coordination group, the Standing Committee on Biocidal Products, and working groups established in the European Chemicals Agency, and to ensure that the employees of the National Public Health Centre that are the members of the Biocidal Products Committee are provided with scientific and technical assistance required for their work in the Committee;

3.4.2. to exercise the functions of national helpdesk, in collaboration with the State Food and Veterinary Service, that should consult the applicants, the manufacturers of the biocidal products, the importers, the downstream users, and other interested parties on the matters related to their relevant responsibilities, obligations and rights laid down in Regulation (EU) No 528/2012;

3.4.3. to present reports to the Commission on the implementation of Regulation (EU) No 528/2012 in Lithuania;

3.4.4. to submit proposals for the Commission to enter or remove active substances to the Annex I of Regulation (EU) No 528/2012, as well as restrict entries of active substances;

3.4.5. to submit proposals for the Commission to exempt the biocidal products from the European Union authorisation in Lithuania (hereinafter referred to as ‘the Union’) or adapt conditions of the authorisation of the Union to Lithuania;

3.4.6. to send explanations concerning the conditions for granting an authorisation for biocidal products that do not comply with the requirements of Regulation (EU) No 528/2012 to the competent authorities of the reference Member States, applicants and authorisation holders, and receive relevant explanations from them;

3.4.7. to provide the public with the information about the benefits and risks associated with biocidal products and ways of minimising their use;

3.4.8. to receive notifications from authorisation holders concerning the making available on the market of biocidal products authorised in accordance with the simplified authorisation procedure; if the biocidal products authorised in accordance with the simplified authorisation procedure do not comply with the requirements of Regulation (EU) No 528/2012, it should refer that matter to the coordination group;

3.4.9. to ensure the installation and functioning of hardware and software required for the implementation of the requirements of Regulation (EU) No 528/2012, the functioning of the Register for Biocidal Products, and the protection of confidential information concerning the biocidal products provided by applicants;

3.4.10. to authorise biocidal products, as well as authorise biocidal products in accordance with the simplified authorisation procedure and the mutual recognition; to renew the authorisation, to modify and cancel the authorisation, to perform a comparative assessment of biocidal products; to grant a parallel trade permit for a biocidal product that is authorised in another Member State (‘parallel trade permit’); in accordance with the provision on derogations from the requirements, for a period not exceeding 180 days, to permit the making available on the market or limited use of biocidal products which do not fulfil the conditions of authorisation laid down in Regulation (EU) No 528/2012; until a new active substance is approved, to provisionally authorise, for a period not exceeding three years, a biocidal product containing that new active substance; to adjust the terms and conditions of the authorisation or refuse to grant an authorisation under the mutual recognition procedure, in accordance with the criteria set out in Regulation (EU) No 528/2012, with the exception of product-types and uses assigned to the State Food and Veterinary Service laid down in point 3.5 of this Resolution; to make decisions on the authorisation or prohibition of use of an unauthorized biocidal product or a non-approved active substance exclusively for the use in experiments or tests in a biocidal product for the purposes of research or development;

3.4.11. to record and communicate the decisions in relation to the authorisations of biocidal products (authorisation, refusal to grant an authorisation, modification of the authorisation, renewal of the authorisation, cancellation of the authorisation, grant a parallel trade permit, refuse to grant a parallel trade permit, cancel a parallel trade permit) in the Register for Biocidal Products, as well as update that recorded and communicated information according to the relevant amendments;

3.6.1. within the area of supervision of its respective competence to supervise whether:

3.6.2. to perform supervision of the requirements of the advertisement of biocidal products laid down in Regulation (EU) No 528/2012;

3.10.1. the biocidal products are validated in accordance with points 3.4.10 and 3.5 of this Resolution;

3.10.2. the biocidal products are used in accordance with the requirements of the authorisations or permits laid down in points 3.4.10 and 3.5 of this Resolution;

3.10.3. manufacturers of biocidal products maintain, in relation to the manufacturing process, appropriate documentation in paper or electronic format relevant for the quality and safety of the biocidal product they make available on the market and store production batch samples;